Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00006372 · ClinicalTrials.gov registry record · Phase 1
Combination Chemotherapy in Treating Patients With Advanced Solid Tumors
A Phase 1 study, sponsored by Case Comprehensive Cancer Center.
- Completed
- Registry status
- Phase 1
- Development phase
- 10
- Enrollment target
NCT00006372 is a Phase 1 study that has completed, run by Case Comprehensive Cancer Center. The registered enrollment target is 10 participants.
The verdict
NCT00006372, a Phase 1 study, has completed, sponsored by Case Comprehensive Cancer Center.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 10 participants
- Enrollment target
Study Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase I trial to study the effectiveness of combination chemotherapy in treating patients who have advanced solid tumors.
Interventions
- DRUG pegylated liposomal doxorubicin hydrochloride
- DRUG gemcitabine hydrochloride
- DRUG vinorelbine ditartrate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2000-02 |
| Est. Completion | 2005-02 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00006372
The ClinicalTrials.gov registry entry for NCT00006372 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Case Comprehensive Cancer Center, which has 407 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which pegylated liposomal doxorubicin hydrochloride is the first listed.
NCT00006372 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00006372 about?
NCT00006372 is a clinical study titled "Combination Chemotherapy in Treating Patients With Advanced Solid Tumors". RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase I trial to study the effectiveness of combination chemotherapy in treating patients who have advanced solid ...
What is the current status of trial NCT00006372?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 10 participants. The study started on 2000-02. Estimated completion is 2005-02.
What interventions are being tested in trial NCT00006372?
The interventions under investigation include: pegylated liposomal doxorubicin hydrochloride (DRUG), gemcitabine hydrochloride (DRUG), vinorelbine ditartrate (DRUG).
Who is sponsoring clinical trial NCT00006372?
This trial is sponsored by Case Comprehensive Cancer Center, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.